Change in the vertical distribution of the lipid layer thickness after intensive pulse light treatment (IPL; nm) combined with meibomian gland expression (MGX). by Yongwoo Lee (2265172)

Subjects:

Evolution of mean values of posttraumatic stress symptomatology according to sociodemographic and occupational variables from baseline to 12-month. by Beatriz Arregui-Gallego (21553735)

Effects of GJE extract treatment decreased serum ALT and AST levels. by Natnicha Suttawong (22367172)

Data - willing to pay of dog owners. by Fentahun Mengie (20862454)

Subjects:

Data - intention of dog owners. by Fentahun Mengie (20862454)

Subjects:

Map of the study area (shaded in gray). by Fentahun Mengie (20862454)

Subjects:

Mean persistence (±SE) of GO and GO-GA NPs on <i>Callosobruchus maculatus.</i> by Huda H. Elbehery (22492996)

Change in Mean Anxiety Scores Over time by group. by Shaaista Budhani (21030221)

Correlation between Estimated Annual Percentage Change (EAPC) of <i><i>Klebsiella pneumoniae</i></i> associated lower respiratory infection (LRI) and death rates, and Socio-demogra... by Juanjuan Li (399633)

Subjects:

Expression profile of WRKY-TFs and ROS accumulation in susceptible T200 and tolerant TME3 cassava genotypes. by Bulelani L. Sizani (21485746)

Subjects:

Transcript levels of MAPK, NIK, NLR and SA-depended gene pathways and responsive genes. by Bulelani L. Sizani (21485746)

Subjects:

Transcript levels of MAPK, NIK, NLR and SA-dependent gene pathways and responsive genes. by Bulelani L. Sizani (21485746)

Subjects:

South African cassava mosaic virus (SACMV) genome structure and the effect of SACMV on cassava leaf symptoms. by Bulelani L. Sizani (21485746)

Subjects:

Blood Pressure and LDL-C During Follow-up. by Karl Ingard (22582091)

Subjects:

Median EQ-5D-3L index values during 5 years of follow-up. by Karl Ingard (22582091)

Subjects:

Baseline Characteristics of Included Patients. by Karl Ingard (22582091)

Subjects:

Subgroup Analysis of the Occurrence of Secondary Endpoints. by Karl Ingard (22582091)

Subjects:

Study flow chart. by Karl Ingard (22582091)

Subjects:

Kaplan-Meier curve of the primary outcome. by Karl Ingard (22582091)

Subjects:

Number of Patients Who Reached the Primary and Secondary Endpoints During Follow-up. by Karl Ingard (22582091)

Subjects: